Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
CRT 2019: Real World Validation of the Resting Full-Cycle Ratio (RFR)
Author(s): Gautam Kumar Added: 5 years ago
Dr Gautam Kumar (Emroy Clinic, Atlana, US) discusses the Real World Validation of the Resting Full-Cycle Ratio (RFR): A Novel Non-Hyperemic Index of Coronary Artery Stenosis Severity. Filmed on-site at CRT 2019 by Radcliffe Cardiology Questions: 1. What is RFR and how does it compliment/compare to other physiologic indices? 2. What data are you presenting at CRT 2019? 3. What conclusions can… View more

Intervention
EuroPCR 22: ROLEX Study Finds Promising Results in CAD Pts With the Resolute Onyx
Author(s): Giuseppe Tarantini Added: 1 year ago
Filmed at EuroPCR 2022, Dr Giuseppe Tarantini (University of Padua Medical School, IT) joins us for a short interview on the ROLEX study (NCT03316833). This was a European multi-centre registry, where patients with left main coronary artery disease were treated with a new-generation zotarolimus-eluting stent, the Resolute Onyx. Discussion points: 1. Aim of This Study 2. Resolute Onyx 3. Patient… View more

Prevention & Chronic Conditions
Role of Inflammation in Coronary Epicardial and Microvascular Dysfunction
Author(s): Shigeo Godo , Jun Takahashi , Satoshi Yasuda , et al Added: 3 years ago

Prevention & Chronic Conditions
Ep 1: Women and Heart Disease
Author(s): Martha Gulati , Erin D Michos Added: 2 years ago
Did you know that CV disease is the leading cause of death in women and that women are more likely to die of heart disease compared to men? Dr Erin Michos (Johns Hopkins Uni, US) and Dr Martha Gulati (Uni of Arizona, US) join us on the inaugural episode of the ECR podcast series to discuss issues surrounding women in heart disease. Together they explore a variety of topics that are addressed in… View more

CV Disease in Special Populations

Demographic
Author(s): Martin H Deininger , Juergen Buttler Added: 3 years ago
The association of electrocardiographic (ECG) abnormalities and intracerebral, particularly aneurysmal subarachnoid haemorrhage (SAH) is a well-known phenomenon. ECG alterations are observed in 50-100% of patients during the acute stage of SAH. Frequently, these effects are clinically not important. Some SAH patients, however, have structural cardiac damage with elevation of creatine kinase… View more

Imaging & Diagnostics

Heart Failure
Foreword

Article

Author(s): Juan Carlos Kaski Added: 3 years ago
It is a great pleasure for me to present a new issue of ECR. This issue has, in addition to our customary article devoted to a ‘Cardio Master’, 11 great papers grouped under four major sections: Ischaemic Heart Disease, Heart Failure and Arrhythmias, Risk Factors and Cardiovascular Disease Prevention and Pharmacotherapy. The latter, guest-edited by the International Society of Cardiovascular… View more

Heart Failure

Prevention & Chronic Conditions
Author(s): Abhiram Prasad Added: 3 years ago
Takotsubo cardiomyopathy (TC) or syndrome was first described more than 2 decades ago by Dote and colleagues in Japan, but has since been increasingly recognised around the world.1 Takotsubo is the Japanese name for a the traditional octopus trapping pot that has a round bottom and narrow neck, resembling the appearance the left ventricle during the acute presentation (see Figure 1).2 Although,… View more

Heart Failure

Prevention & Chronic Conditions
Personalised Approaches to Improving the Effect of Anti-platelet Agents: Where Do We Stand?
Author(s): Lucas C Godoy , Michael E Farkouh Added: 3 years ago
Clopidogrel is the most widely prescribed P2Y12 inhibitor in the world despite the development of newer and more potent agents.1,2 Clopidogrel is administered as a pro-drug and needs to be metabolised by the cytochrome P450 enzymes (particularly by CYP2C19) in order to have biological activity.3 Patients with loss of function (LOF) variants of the CYP2C19 gene have decreased serum levels of… View more

Anticoagulation

Prevention & Chronic Conditions
Added: 3 years ago
Plasma Osteopontin Levels Predict Future Cardiovascular Events in Angina Patients Italian researchers from the University of Pavia have found that increased levels of plasma osteopontin are an independent predictor of future adverse cardiovascular (CV) events in patients with chronic stable angina. The findings, published in the April issue of the European Heart Journal, show the investigators… View more

Prevention & Chronic Conditions
Microvascular Angina: Diagnosis and Management
Author(s): Haider Aldiwani , Suzan Mahdai , Ghaith Alhatemi , et al Added: 2 years ago

Intervention